Patricia S Steeg Selected Research

Histidine Kinase

2/2018	The relationship of NM23 (NME) metastasis suppressor histidine phosphorylation to its nucleoside diphosphate kinase, histidine protein kinase and motility suppression activities.
8/2008	Clinical-translational approaches to the Nm23-H1 metastasis suppressor.
2/2003	Basic and translational advances in cancer metastasis: Nm23.
8/2002	Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patricia S Steeg Research Topics

Disease

62	Neoplasms (Cancer) 11/2021 - 11/2002
60	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2002
55	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2002
36	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2007
6	Triple Negative Breast Neoplasms 01/2019 - 10/2009
6	Neoplasm Micrometastasis 10/2015 - 08/2008
2	Fibrosis (Cirrhosis) 05/2018 - 01/2015
2	Osteosarcoma (Osteogenic Sarcoma) 08/2014 - 02/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2010 - 09/2007
1	Gliosis 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 05/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Inflammation (Inflammations) 11/2019
1	Neuroinflammatory Diseases 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2015

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2019 - 09/2007
17	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2002
7	Small Interfering RNA (siRNA)IBA 01/2019 - 08/2007
6	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 10/2009
6	Phosphotransferases (Kinase)IBA 02/2015 - 02/2003
5	Biological ProductsIBA 01/2021 - 02/2003
5	Lysophosphatidic Acid ReceptorsIBA 05/2018 - 08/2007
5	Biomarkers (Surrogate Marker)IBA 12/2016 - 07/2006
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 04/2007
5	Messenger RNA (mRNA)IBA 12/2011 - 05/2007
4	Temozolomide (Temodar)FDA LinkGeneric 05/2020 - 02/2008
4	CytokinesIBA 11/2019 - 12/2008
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2007
4	Histidine KinaseIBA 02/2018 - 08/2002
4	Trastuzumab (Herceptin)FDA Link 03/2015 - 10/2005
4	Lapatinib (GW572016)FDA Link 02/2015 - 08/2008
4	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 11/2014 - 09/2003
3	Histidine (L-Histidine)FDA Link 02/2018 - 08/2002
3	Hormones (Hormone)IBA 11/2014 - 05/2005
3	pazopanib FDA Link 06/2013 - 01/2011
2	AntibodiesIBA 01/2021 - 11/2020
2	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
2	human ERBB2 proteinIBA 11/2020 - 03/2015
2	Estrogen ReceptorsIBA 01/2019 - 01/2007
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2007
2	Dextrans (Dextran)FDA Link 01/2018 - 11/2016
2	Coloring Agents (Dyes)IBA 01/2018 - 11/2016
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2016 - 11/2013
2	Texas redIBA 12/2016 - 11/2016
2	Complementary DNA (cDNA)IBA 07/2014 - 08/2008
2	Tyrosine Kinase InhibitorsIBA 06/2013 - 01/2013
2	Tyrosine (L-Tyrosine)FDA Link 06/2013 - 02/2003
2	IronIBA 07/2011 - 01/2007
2	Radiation-Sensitizing AgentsIBA 05/2011 - 02/2008
2	Histone Deacetylase InhibitorsIBA 10/2010 - 06/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2010 - 03/2006
2	Vorinostat FDA Link 10/2009 - 06/2009
2	KSR-1 protein kinaseIBA 08/2008 - 08/2002
2	SteroidsIBA 08/2008 - 09/2003
2	AgarIBA 05/2005 - 09/2003
2	Serine (L-Serine)FDA Link 02/2003 - 08/2002
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Semaphorin-3AIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2020
1	prexasertibIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Transferrin (beta 2 Transferrin)IBA 01/2019
1	tropomyosin kinaseIBA 01/2019
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2019
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019
1	Death Domain ReceptorsIBA 01/2019
1	Dynamin IIIBA 01/2019
1	Dynamins (Dynamin)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	CaspasesIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	Nucleoside-Diphosphate KinaseIBA 02/2018
1	Succinic Acid (Succinate)IBA 02/2018
1	phosphohistidineIBA 02/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2016
1	MicroRNAs (MicroRNA)IBA 11/2015
1	salicylhydroxamic acid (SHAM)IBA 10/2015
1	Capecitabine (Xeloda)FDA Link 02/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2015
1	IntegrinsIBA 01/2015
1	Mitogen-Activated Protein Kinase 14IBA 10/2014
1	tempolIBA 07/2014

Therapy/Procedure

30	Therapeutics 11/2021 - 02/2003
5	Drug Therapy (Chemotherapy) 01/2019 - 10/2009
5	Lasers (Laser) 03/2014 - 11/2002
4	Radiotherapy 01/2019 - 08/2008
2	Craniotomy 11/2016 - 06/2013
2	Injections 07/2014 - 11/2013
2	Chemoprevention 05/2011 - 12/2006
1	Secondary Prevention 05/2020
1	Combined Modality Therapy 01/2019
1	Immunotherapy 01/2019
1	Ligation 03/2015